Abstract: A composite porous membrane contains at least one porous base layer and at least one uniaxially stretched coating layer located on at least one side surface of the porous base layer. For example, the composite porous membrane comprises at least one porous base layer and at least one nanofiber-like non-polyolefin polymer porous layer oriented along the transverse stretching direction of the composite porous membrane and located on one or two side surfaces of the porous base layer, or the composite porous membrane comprises a biaxially stretched polypropylene porous base layer and a uniaxially stretched coating layer located on at least one side surface of the porous base layer. The composite porous membrane is coated with a coating solution prior to transversely stretching. The nanofiber-like non-polyolefin polymer porous layer may reduce cracking of the composite porous membrane in the machine direction.

Abstract: A type of substituted penta-fused hexa-heterocyclic compounds having selective inhibition for PIKfyve kinase, a pharmaceutically acceptable salt and pharmaceutically acceptable solvate thereof, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with PIKfyve in vivo, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.

Abstract: The present invention relates to a compound having the following formula, or a stereoisomer thereof, a prodrug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, preparation method thereof, pharmaceutical composition comprising the same and use of the compound in the manufacture of a medicament for preventing or treating tumor, wherein the substituents are as defined in the specification.

Abstract: The present invention relates to thienopyrimidine compound, preparation method thereof, pharmaceutical composition and use thereof, and in particular to a type of compounds having ALK and/or c-Met selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with anaplastic lymphoma kinase in vivo, and in the manufacture of a medicament for preventing or treating a disease associated with angiogenesis or cancer metastasis, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.

Abstract: A composite porous membrane contains at least one porous base layer and at least one uniaxially stretched coating layer located on at least one side surface of the porous base layer. For example, the composite porous membrane comprises at least one porous base layer and at least one nanofiber-like non-polyolefin polymer porous layer oriented along the transverse stretching direction of the composite porous membrane and located on one or two side surfaces of the porous base layer, or the composite porous membrane comprises a biaxially stretched polypropylene porous base layer and a uniaxially stretched coating layer located on at least one side surface of the porous base layer. The composite porous membrane is coated with a coating solution prior to transversely stretching. The nanofiber-like non-polyolefin polymer porous layer may reduce cracking of the composite porous membrane in the machine direction.

Abstract: The present invention relates to thienopyrimidine compound, preparation method thereof, pharmaceutical composition and use thereof, and in particular to a type of compounds having ALK and/or c-Met selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with anaplastic lymphoma kinase in vivo, and in the manufacture of a medicament for preventing or treating a disease associated with angiogenesis or cancer metastasis, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.

Abstract: A type of substituted penta-fused hexa-heterocyclic compounds having selective inhibition for PIKfyve kinase, a pharmaceutically acceptable salt and pharmaceutically acceptable solvate thereof, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with PIKfyve in vivo, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.

Abstract: The present invention relates to a compound having the following formula, or a stereoisomer thereof, a prodrug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, preparation method thereof, pharmaceutical composition comprising the same and use of the compound in the manufacture of a medicament for preventing or treating tumor, wherein the substituents are as defined in the specification.

Abstract: The present invention relates to a compound of formula I, a stereoisomer, a prodrug, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, and a process for preparing the same, a pharmaceutical composition comprising the same, and use of the compound in the preparation of medicine preventing and treating tumors, wherein the substituents are as defined in the specification.

Abstract: The present invention relates to thienopyrimidine compound, preparation method thereof, pharmaceutical composition and use thereof, and in particular to a type of compounds having ALK and/or c-Met selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with anaplastic lymphoma kinase in vivo, and in the manufacture of a medicament for preventing or treating a disease associated with angiogenesis or cancer metastasis, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.

Abstract: The present invention relates to a compound of formula I, a stereoisomer, a prodrug, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, and a process for preparing the same, a pharmaceutical composition comprising the same, and use of the compound in the preparation of medicine preventing and treating tumors, wherein the substituents are as defined in the specification.

Abstract: A method and apparatus for dispensing fragrance into the air in the vicinity of the user comprises a liquid reservoir and a solid-state microfluidic controller actuated by a solid-state switching device. The microfluidic device is designed to pump the fragrant material onto the surface of the device, from which the material evaporates, thereby releasing a scent under the manipulation of an electrical circuit, which is preferably battery powered. The entire device consisting of fluid reservoir, pump or valve, power supply, and electronic controls, is preferably small enough to be conveniently attached to clothing or worn by the user. The device may further be contained in a substantially decorative housing and worn like jewelry. The device may be pre-programmed to dispense automatically according to a preset cycle, or it may be adjustable or programmable to some degree by the user.

Abstract: A solid state thermoelectric converter includes a thermally insulating separator layer, a semiconducting collector and an electron emitter. The electron emitter comprises a metal nanoparticle layer or plurality of metal nanocatalyst particles disposed on one side of said separator layer. A first electrically conductive lead is electrically coupled to the electron emitter. The collector layer is disposed on the other side of the separator layer, wherein the thickness of the separator layer is less than 1 ?m. A second conductive lead is electrically coupled to the collector layer.

Abstract: A solid state thermoelectric converter includes a thermally insulating separator layer, a semiconducting collector and an electron emitter. The electron emitter comprises a metal nanoparticle layer or plurality of metal nanocatalyst particles disposed on one side of said separator layer. A first electrically conductive lead is electrically coupled to the electron emitter. The collector layer is disposed on the other side of the separator layer, wherein the thickness of the separator layer is less than 1 ?m. A second conductive lead is electrically coupled to the collector layer.

Abstract: A method and apparatus for dispensing fragrance into the air in the vicinity of the user comprises a liquid reservoir and a solid-state microfluidic controller actuated by a solid-state switching device. The microfluidic device is designed to vaporize or pump the fragrant material into the air and thereby release a scent under the manipulation of an electrical circuit, which is preferably battery powered. The entire device consisting of fluid reservoir, pump or valve, power supply, and electronic controls, is preferably small enough to be conveniently attached to clothing or worn by the user. The device may further be contained in a substantially decorative housing and worn like jewelry. The device may be pre-programmed to dispense automatically according to a preset cycle, or it may be adjustable or programmable to some degree by the user.

Abstract: A microfluidics device includes a plurality of interaction cells and fluid control means including i) means for providing to the interaction cells a preparation fluid, and ii) means for providing to the interaction cells a sample fluid, wherein each interaction cell receives a different sample fluid. A plurality of microcantilevers may be disposed in each of the interaction cells, wherein each of the plurality of microcantilevers configured to deflect in response to an interaction involving a component of the sample fluid.

Abstract: A microfluidics device includes a plurality of interaction cells and fluid control means including i) means for providing to the interaction cells a preparation fluid, and ii) means for providing to the interaction cells a sample fluid, wherein each interaction cell receives a different sample fluid. A plurality of microcantilevers may be disposed in each of the interaction cells, wherein each of the plurality of microcantilevers configured to deflect in response to an interaction involving a component of the sample fluid.

Abstract: A number of thermal elements are used in a microfluidic device to move or manipulate nano-liter and pico-liter amounts of adsorbed fluid analytes and reagents on the device surface. All of the basic microfluidic operations of transport, merge, subdivide, separate, sort, remove, and capture are provided. A typical device embodiment has a flat or curved surface with the thermal elements located at or near the surface and arranged in any of a number of patterns that make possible specific manipulations of the adsorbed fluids on the surface. The thermal elements may be electrical resistive heaters or Peltier Effect junctions, and are activated by a series of electrical pulses from a control means. The heated or cooled thermal elements produce localized thermal gradients in the surface which in turn induce a surface tension gradient between the adsorbed fluid and the surface, making possible a variety of fluid manipulations on the surface.